Paper
3 December 2007 Pharmacology of photosensitizer in rats with metastatic breast cancer: time point determination for photodynamic therapy (PDT) treatment of vertebral metastases
Margarete K. Akens D.V.M., Albert J. M. Yee M.D., Lothar Lilge, Shane Burch M.D., Cari Whyne, Brian C Wilson, Stuart K. Bisland
Author Affiliations +
Abstract
Photodynamic therapy (PDT) as a non-radiative treatment has been applied successfully in various cancers. PDT may be a useful adjunct in the treatment of vertebral metastases. PDT efficacy requires the administration of a photosensitiser drug followed by subsequent drug activation by wavelength specific light. The study purpose was to establish the pharmacokinetic profiles for 2 photosensitisers, BPD-MA and 5-ALA induced PpIX, to determine the optimal drug-light interval for vertebral PDT.
© (2007) COPYRIGHT Society of Photo-Optical Instrumentation Engineers (SPIE). Downloading of the abstract is permitted for personal use only.
Margarete K. Akens D.V.M., Albert J. M. Yee M.D., Lothar Lilge, Shane Burch M.D., Cari Whyne, Brian C Wilson, and Stuart K. Bisland "Pharmacology of photosensitizer in rats with metastatic breast cancer: time point determination for photodynamic therapy (PDT) treatment of vertebral metastases", Proc. SPIE 5969, Photonic Applications in Biosensing and Imaging, 596917 (3 December 2007); https://doi.org/10.1117/12.628730
Advertisement
Advertisement
RIGHTS & PERMISSIONS
Get copyright permission  Get copyright permission on Copyright Marketplace
KEYWORDS
Spinal cord

Photodynamic therapy

Tissues

Breast cancer

Bioluminescence

Pharmacology

Kidney

Back to Top